Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
Ultragenyx Pharmaceutical Inc. (RARE)
Today's Latest Price: $100.50 USD
Updated Oct 30 4:00pm
Add RARE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
RARE Stock Summary
- The ratio of debt to operating expenses for Ultragenyx Pharmaceutical Inc is higher than it is for about only 9.09% of US stocks.
- RARE's price/sales ratio is 28.52; that's higher than the P/S ratio of 94.17% of US stocks.
- Revenue growth over the past 12 months for Ultragenyx Pharmaceutical Inc comes in at 154.89%, a number that bests 96.23% of the US stocks we're tracking.
- Stocks that are quantitatively similar to RARE, based on their financial statements, market capitalization, and price volatility, are BLUE, AGIO, FPRX, RGNX, and APTX.
- Visit RARE's SEC page to see the company's official filings. To visit the company's web site, go to www.ultragenyx.com.
RARE Stock Price Chart Interactive Chart >
RARE Price/Volume Stats
| Current price | $100.50 | 52-week high | $102.14 |
| Prev. close | $95.00 | 52-week low | $31.99 |
| Day low | $93.84 | Volume | 1,256,000 |
| Day high | $102.14 | Avg. volume | 502,668 |
| 50-day MA | $86.26 | Dividend yield | N/A |
| 200-day MA | $70.86 | Market Cap | 6.14B |
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
Loading social stream, please wait...